In a multi-institute collaborative study, we assessed the potential clinical utility of thyroid hormone suppression therapy on benign multinodular thyroid disease. The study was performed using our previously developed method of quantitative research synthesis. This approach involved systematic review of the literature for relevant clinical studies and expert opinions, meta-analysis of selected interventional studies, surveys of NIH endocrinology practitioners for therapeutic decisions in hypothetic patients with benign multinodular thyroid disease, practice validation in NIH patients treated with levothyroxine suppression for benign multinodular thyroid disease, and application of Hill?s criteria to assess causality between thyroid suppression therapy and regression of benign nodules. Similar to our earlier observation for the effect of thyroid suppression therapy on benign solitary thyroid nodules, we found that a subset of patients with benign multinodular thyroid disease responded to this medical therapy with clinically significant reduction in nodule size. Consequently, an initial trial of this therapy is warranted in patients with benign multinodular thyroid disease in the absence of contraindication(s) to levothyroxine administration. In another study, we evaluated a case in which increased doses of levothyroxine replacement therapy were required to achieve euthyroid status in a patient with nephrotic syndrome. The clinical picture thus mimicked an """"""""inappropriate"""""""" thyroid-stimulating hormone (TSH) secretion syndrome.We analyzed the effect of various blood collection tubes on the measurements of free thyroxine (FT4), free iodothyronine (FT3), and TSH (thyroid-stimulating hormone or thyrotropin) with different nonisotopic methods. We observed clinically significant effects only with one type of collection tube on some assays. Nevertheless, the findings indicate that routine evaluation of these tubes is warranted before their use for thyroid function testing.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010305-02
Application #
6431868
Study Section
Cognition and Perception Study Section (CP)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Celi, Francesco S; Zemskova, Marina; Linderman, Joyce D et al. (2009) The pharmacodynamic equivalence of levothyroxine and liothyronine. A randomized, double blind, cross-over study in thyroidectomized patients. Clin Endocrinol (Oxf) :
Bowen, Raffick A R; Vu, Chi; Remaley, Alan T et al. (2007) Differential effect of blood collection tubes on total free fatty acids (FFA) and total triiodothyronine (TT3) concentration: a model for studying interference from tube constituents. Clin Chim Acta 378:181-93
Eisenhofer, Graeme; Goldstein, David S; Sullivan, Patricia et al. (2005) Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068-75
Eisenhofer, Graeme; Lenders, Jacques W M; Goldstein, David S et al. (2005) Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51:735-44
Bowen, Raffick A R; Chan, Yung; Ruddel, Mark E et al. (2005) Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720. Clin Chem 51:1874-82
Bowen, Raffick A R; Chan, Yung; Cohen, Joshua et al. (2005) Effect of blood collection tubes on total triiodothyronine and other laboratory assays. Clin Chem 51:424-33
McGriff, Nayahmka J; Csako, Gyorgy; Gourgiotis, Loukas et al. (2002) Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34:554-64
Csako, G; McGriff, N J; Rotman-Pikielny, P et al. (2001) Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders. Ann Pharmacother 35:1578-83
Collins, M T; Remaley, A T; Csako, G et al. (2000) Increased levothyroxine requirements presenting as ""inappropriate"" TSH secretion syndrome in a patient with nephrotic syndrome. J Endocrinol Invest 23:383-92
Csako, G; Byrd, D; Wesley, R A et al. (2000) Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis. Medicine (Baltimore) 79:26-Sep

Showing the most recent 10 out of 11 publications